aTYR PHARMA INC Deferred Tax Assets, Gross
aTYR PHARMA INC (ATYR) had Deferred Tax Assets, Gross of $143.35 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-03-05
- 2025-12-31: Deferred Tax Assets, Gross $143.35M.
- 2024-12-31: Deferred Tax Assets, Gross $125.41M.
- 2023-12-31: Deferred Tax Assets, Gross $109.40M.
- 2022-12-31: Deferred Tax Assets, Gross $97.01M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2025-12-31 | $143.35M 10-K · filed 2026-03-05 |
| 2024-12-31 | $125.41M 10-K · filed 2026-03-05 |
| 2023-12-31 | $109.40M 10-K · filed 2025-03-13 |
| 2022-12-31 | $97.01M 10-K · filed 2024-03-14 |
| 2021-12-31 | $84.38M 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |